Surfacide’s Helios+ UV-C System is one of only two devices authorized by the FDA as a Class II medical device for whole room microbial reduction. Helios+ delivers validated efficacy and regulatory assurance hospitals can trust. Its patented Power of Three design uses a trio of emitters to provide comprehensive, 360-degree disinfection – significantly reducing pathogens on surfaces and in the air in a single cycle. Engineered with workflow in mind, Helios+ features intuitive operation, real-time reporting and robust data capture to support compliance with The Joint Commission, DNV and CMS standards for environmental disinfection. Backed by a decade of clinical use and peer-reviewed evidence, Helios+ enhances existing cleaning protocols without delaying room turnover, helping infection prevention and EVS teams achieve safer, more efficient environments of care. From ORs and patient rooms to specialty spaces, Helios+ empowers hospitals to standardize disinfection with confidence – supported by FDA authorization, proven performance and measurable results.
